Elevance Health Lowers Profit Outlook Despite Strong Q1 Revenue Growth
Elevance Health lowers full-year profit forecast despite Q1 revenue growth driven by higher premiums and membership gains in Medicare Advantage and ACA.
Elevance Health Q1 2025: Revenue Growth, Medicare Advantage Expansion, and Carelon Rx Gains
Elevance Health reports 15% revenue growth in Q1 2025 driven by Medicare Advantage expansion, premium increases, and CarelonRx portfolio growth, highlighting ongoing healthcare market evolution.
Trump Executive Order Targets Medicare Drug Price Negotiation Discrepancies
President Trump's executive order prompts potential changes in Medicare drug price negotiation, affecting pharmaceutical pricing, Medicare spending, and FDA drug import regulations. Epic Systems also shifts to a more public presence in healthcare IT.
Insights on Medicare Affordability Challenges and Reform Implications
Analysis of Medicare affordability challenges highlights systemic issues and the need for reform in traditional Medicare and Medicare Advantage plans affecting coverage and costs.
Key CMS 2026 Medicare Advantage Final Rule Updates for Insurers
CMS finalizes critical 2026 Medicare Advantage rule changes, including anti-obesity drug coverage exclusion, AI regulatory deferral, and limits on retroactive inpatient stay denials affecting payers and providers.
Elevance Health Q1: Stable Profits Amid Rising Medical Costs and Legal Challenges
Elevance Health reports steady Q1 profits with growth in Medicare Advantage and Carelon despite elevated medical costs and legal challenges.
Elevance Reports Stable Medicare Advantage Costs Amid Market Volatility
Elevance Health's Q1 report shows Medicare Advantage utilization in line with expectations, Medicaid rate progress, and ACA expansion amid market volatility.
Medicare Advantage Market Growth Slows in Early 2025, Reports MFA
Mark Farrah Associates reports a slowdown in Medicare Advantage market growth with detailed enrollment and market share data for early 2025. Key tools aid insurers in competitive analysis post-Open Enrollment Period.
Healthcare Sector Faces Mixed Market Trends Amid Insurer Losses and Pharma Gains
April 2025 market update reveals insurer stock declines amid UnitedHealth earnings miss, offset by pharma gains led by Eli Lilly's drug innovation and strong healthcare sector earnings projections.
Medicare Advantage Costs, Challenges, and Broker Roles: Insights from SCAN Health Plan CEO
Medicare Advantage increases federal spending but offers lower out-of-pocket costs for seniors. SCAN CEO Sachin Jain highlights program flaws, risk adjustment abuses, and broker roles.